Evidence map›Paper›PMID 33047481›Full record

GuidelinePediatric diabetes2020

Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA).

Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Rémi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nick S Oliver, Dessi P Zaharieva and 20 more

Registry-linked trialOpen access · hybridAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Pediatric diabetes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07550608 (Effects of Pre-Exercise Basal Insulin Manipulation on Glucose Dynamics in Females vs. Males With Type 1 Diabetes), which is not on this map. Cited by 46 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 4 pooled it
6.1field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07550608 nacompletednot on this mapstarted 2023, after this paper: background citation

Effects of Pre-Exercise Basal Insulin Manipulation on Glucose Dynamics in Females vs. Males With Type 1 Diabetes: A Cross-Over Study

TypeinterventionalSponsorNaama ConstantiniRan2023 to 2025Enrolled18ConditionsType 1 DiabetesArms50% Pre-Exercise Basal Insulin Rate Reduction (BIRR), Habitual Basal Insulin Rate Maintenance
3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 4 syntheses or guidelines pooled it, 79 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Trial
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Glycemic Management in Adults With Diabetes During Illness.Clinical diabetes : a publication of the American Diabetes Association · 2025
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 20 institutions in 14 countries.

Othmar MoserDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria.ORCID 0000-0002-1661-0685
Michael C RiddellSchool of Kinesiology and Health Science, York University, Toronto, Ontario, Canada.
Max L EcksteinDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria.
Peter AdolfssonDepartment of Pediatrics, The Hospital of Halland, Kungsbacka, Sweden.
Rémi Rabasa-LhoretInstitut de recherches Cliniques de Montréal, Montréal, QC, Canada.
Louisa van den BoomDivision of Pediatric Diabetology, DRK Children's Hospital, Siegen, Germany.
Pieter GillardDepartment of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Kirsten NørgaardSteno Diabetes Center Copenhagen, University of Copenhagen, Copenhagen, Denmark.
Nick S OliverDepartment of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College, London, London, UK.
Dessi P ZaharievaDepartment of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, California, USA.
Tadej BattelinoDepartment of Paediatric Endocrinology, Diabetes and Metabolic Diseases, UMC - University Children's Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.
Carine de BeaufortDepartment of Pediatric Diabetes and Endocrinology, Centre Hospitalier Luxembourg, Luxembourg, Luxembourg.
Richard M BergenstalInternational Diabetes Center, Minneapolis, Minnesota, USA.
Bruce BuckinghamDepartment of Pediatric Endocrinology and Diabetes, Stanford University School of Medicine, Stanford, California, USA.
Eda CengizDepartment of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Asma DeebPaediatric Endocrinology Division, Shaikh Shakhbout Medical City, Abu Dhabi, United Arab Emirates.
Tim HeiseProfil, Neuss, Germany.
Simon HellerDepartment of Oncology & Metabolism, The Medical School, University of Sheffield, Sheffield, UK.
Aaron J KowalskiJDRF, New York, New York, USA.
Lalantha LeelarathnaManchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Chantal MathieuDepartment of Endocrinology, University Hospitals Leuven, KU Leuven, Leuven, Belgium.
Christoph StettlerDepartment of Diabetes, Endocrinology, Nutritional Medicine and Metabolism, Inselspital, Bern University Hospital and University of Bern, Bern, Switzerland.
Martin TauschmannDepartment of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Hood ThabitManchester Diabetes Centre, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
Emma G WilmotDiabetes Department, Royal Derby Hospital, University Hospitals of Derby and Burton NHSFT, Derby, UK.
Harald SourijDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria.
Carmel E SmartSchool of Health Sciences, University of Newcastle, Callaghan, New South Wales, Australia.
Peter G JacobsDepartment of Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, USA.
Richard M BrackenApplied Sport, Technology, Exercise and Medicine Research Centre (A-STEM), College of Engineering, Swansea University, Swansea, UK.
Julia K MaderDivision of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria.
Medical University of Graz · ATKU Leuven · BEManchester Academic Health Science Centre · GBStanford Medicine · USBahçeşehir University · TRBreakthrough T1D · USCentre Hospitalier de l’Université de Montréal · CACentre Hospitalier de Luxembourg · LUHallands sjukhus Kungsbacka · SEImperial College London · GBInternational Diabetes Federation · BEJohn Hunter Children's Hospital · AUMedical University of Vienna · ATOregon Health & Science University · USProfil Institute for Metabolic Research · DESheffield Teaching Hospitals NHS Foundation Trust · GBSheikh Shakhbout Medical City · AESwansea University · GBUniversity of Bern · CHUniversity of Copenhagen · DK

Funding

Yale Clinical and Translational Science AwardUL1TR001863 · YALE UNIVERSITY · 2025 to 2025
$9.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

Physical exercise is an important component in the management of type 1 diabetes across the lifespan. Yet, acute exercise increases the risk of dysglycaemia, and the direction of glycaemic excursions depends, to some extent, on the intensity and duration of the type of exercise. Understandably, fear of hypoglycaemia is one of the strongest barriers to incorporating exercise into daily life. Risk of hypoglycaemia during and after exercise can be lowered when insulin-dose adjustments are made and/or additional carbohydrates are consumed. Glycaemic management during exercise has been made easier with continuous glucose monitoring (CGM) and intermittently scanned continuous glucose monitoring (isCGM) systems; however, because of the complexity of CGM and isCGM systems, both individuals with type 1 diabetes and their healthcare professionals may struggle with the interpretation of given information to maximise the technological potential for effective use around exercise (ie, before, during and after). This position statement highlights the recent advancements in CGM and isCGM technology, with a focus on the evidence base for their efficacy to sense glucose around exercise and adaptations in the use of these emerging tools, and updates the guidance for exercise in adults, children and adolescents with type 1 diabetes.

Indexed as

Blood Glucose Self-MonitoringExerciseAdolescentAdultBlood GlucoseChildDiabetes Mellitus, Type 1Glycemic ControlHumansHypoglycemic AgentsInsulinBlood GlucoseHypoglycemic AgentsInsulinAdolescentsAdultsCGMChildrenContinuous glucose monitoringExercisePhysical activityPosition statementType 1 diabetes

Identifiers

PMID33047481
PMCPMC7702152
OpenAlexW3092636881

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.